2012598-83-1
2012598-83-1
Chemical Structure
Vardenafil-d4
- CAS No.: 2012598-83-1
- Formula:C23H28D4N6O4S
- Molecular Weight:492.63
InChIKey: SECKRCOLJRRGGV-IWFQOFTGSA-N
SMILES: CCCC1=NC(C)=C2N1N=C(C(C=C(S(=O)(N3C([2H])([2H])C([2H])([2H])N(CC)CC3)=O)C=C4)=C4OCC)NC2=O
Biological Activity: Vardenafil-d4 is deuterium-labeled Vardenafil (HY-B0442)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Vardenafil-d4 | Vardenafil-d4 is deuterium-labeled Vardenafil (HY-B0442). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Vardenafil (Standard) | ≥98% | Vardenafil (Standard) is the analytical standard of Vardenafil. This product is intended for research and analytical applications. Vardenafil is a selective and orally active inhibitor of phosphodiesterase-5 (PDE5), with an IC50 of 0.7 nM. Vardenafil shows inhibitory towards PDE1, PDE6 with IC50s of 180 nM, and 11 nM, while IC50s are >1000 nM for PDE3 and PDE4. Vardenafil competitively inhibits cyclic guanosine monophosphate (cGMP) hydrolysis and thus increases cGMP levels. Vardenafil can be used for the research of erectile dysfunction, hepatitis, diabetes-. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Vardenafil-d5 | Vardenafil-d5 is deuterium labeled Vardenafil. Vardenafil is a selective, orally active, potent inhibitor of phosphodiesterase-5 (PDE5), with an IC50 of 0.7 nM. Vardenafil shows selectivity over PDE1 (180 nM), PDE6 (11 nM), PDE2, PDE3, and PDE4 (>1000 nM). Vardenafil competitively inhibits cyclic guanosine monophosphate (cGMP) hydrolysis and thus increases cGMP levels. Vardenafil can be used for the research of erectile dysfunction. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Vardenafil | 99.81% | Vardenafil is a selective and orally active inhibitor of phosphodiesterase-5 (PDE5), with an IC50 of 0.7 nM. Vardenafil shows inhibitory towards PDE1, PDE6 with IC50s of 180 nM, and 11 nM, while IC50s are >1000 nM for PDE3 and PDE4. Vardenafil competitively inhibits cyclic guanosine monophosphate (cGMP) hydrolysis and thus increases cGMP levels. Vardenafil can be used for the research of erectile dysfunction, hepatitis, diabetes-. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
